PIA
AUPH icon

Prakash Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Prakash Investment Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,200
Closed -$73.4K – 82
2025
Q4 		$73.4K Buy
+13,200
New +$187K 0.05% 79

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prakash Investment Advisors's AUPH Position: Q1 2026 in Review

Prakash Investment Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 13,200 shares — an estimated $73.4K sold.

Prakash Investment Advisors first reported a position in AUPH in Q4 2025 and held it in 1 quarter. The position peaked at $73.4K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Prakash Investment Advisors reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Prakash Investment Advisors sold 13,200 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $73.4K.
  • Prakash Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Prakash Investment Advisors's Aurinia Pharmaceuticals position peaked at $73.4K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Prakash Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.